Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights into posttranslational modifications of proteins during bull sperm capacitation. | Cell Commun Signal | 2023 | 37046330 | PubTator, text mining | PubMed |
| Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment. | Front Immunol | 2023 | 37033960 | PubTator, text mining | PubMed |
| Tumour microenvironment in pheochromocytoma and paraganglioma. | Front Endocrinol (Lausanne) | 2023 | 37033265 | PubTator, text mining | PubMed |
| Histologic re‑evaluation of a population‑based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification. | Oncol Lett | 2023 | 37033104 | PubTator, text mining | PubMed |
| Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37025591 | PubTator, text mining | PubMed |
| TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia. | Open Med (Wars) | 2023 | 37016705 | PubTator, text mining | PubMed |
| Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies. | Front Oncol | 2023 | 37007094 | PubTator, text mining | PubMed |
| Cholesterol: An Important Determinant of Muscle Atrophy in Astronauts. | J Biotechnol Biomed | 2023 | 37006714 | PubTator, text mining | PubMed |
| Gene expression variability in long-term survivors of childhood cancer and cancer-free controls in response to ionizing irradiation. | Mol Med | 2023 | 36997855 | PubTator, text mining | PubMed |
| Phaeochromocytoma in a patient with a Birt-Hogg-Dubé syndrome phenotype. | BMJ Case Rep | 2023 | 36997239 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: Mechanisms and therapeutics. | MedComm (2020) | 2023 | 36994237 | PubTator, text mining | PubMed |
| Sustained IP3-linked Ca2+ signaling promotes progression of triple negative breast cancer cells by regulating fatty acid metabolism. | Front Cell Dev Biol | 2023 | 36994106 | PubTator, text mining | PubMed |
| A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity. | Int J Mol Sci | 2023 | 36982825 | PubTator, text mining | PubMed |
| Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma. | Int J Mol Sci | 2023 | 36982568 | PubTator, text mining | PubMed |
| Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth. | Int J Mol Sci | 2023 | 36982351 | PubTator, text mining | PubMed |
| A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata. | Genes (Basel) | 2023 | 36981015 | PubTator, text mining | PubMed |
| MiRNAs Action and Impact on Mitochondria Function, Metabolic Reprogramming and Chemoresistance of Cancer Cells: A Systematic Review. | Biomedicines | 2023 | 36979672 | PubTator, text mining | PubMed |
| Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy. | Biomedicines | 2023 | 36979633 | PubTator, text mining | PubMed |
| The Commensal Anaerobe Veillonella dispar Reprograms Its Lactate Metabolism and Short-Chain Fatty Acid Production during the Stationary Phase. | Microbiol Spectr | 2023 | 36975840 | PubTator, text mining | PubMed |
| [Advances in the fumarate hydratase-deficient diseases]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 36973212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=22